Mackenzie Toliver

Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL.

G. Pardo, J. Guthridge, Y. Mao-Draayer, 2022, Multiple sclerosis and related disorders.

ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model.

M. Lerner, M. Zalles, N. Smith, 2021, Multiple sclerosis and related disorders.